PHILADELPHIA CHROMOSOME POSITIVE
Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo tackles Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests a combination of two drugs, blinatumomab and ponatinib, in adults with a specific type of acute lymphoblastic leukemia (ALL) that has the Philadelphia chromosome. The goal is to see if this combo can better control the disease, especially in patients whose cancer…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:27 UTC
-
New combo aims to deeply suppress leukemia in Early-Stage patients
Disease control Recruiting nowThis study is for people newly diagnosed with a type of leukemia called chronic myeloid leukemia (CML). It tests whether adding a drug called ASTX727 to the standard treatment dasatinib can better control the cancer. About 70 participants will receive the combination and be monit…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New combo aims to control tough leukemia
Disease control Recruiting nowThis study tests whether combining two drugs, blinatumomab and asciminib, can help control Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in adults. About 40 participants will receive the combination to see if it is safe and effective. The goal is to mana…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Heart shield: new study tests drug to prevent chemo side effects
Disease control Recruiting nowThis study tests whether a drug called dexrazoxane can protect the heart from damage caused by chemotherapy in people with certain blood cancers, like acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). About 100 participants will receive dexrazoxane alongs…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC